Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
暂无分享,去创建一个
G. Réus | J. Quevedo | J. Hallak | J. Crippa | A. Zuardi | F. Kapczinski | L. Stertz | J. P. Pinto | J. Fortunato | R. Stringari | Tamires R. Kirsch
[1] G. Réus,et al. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. , 2008, Basic & clinical pharmacology & toxicology.
[2] Eric J. Nestler,et al. The molecular neurobiology of depression , 2008, Nature.
[3] Hiroshi Morita,et al. Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities , 2008, Journal of Natural Medicines.
[4] G. Réus,et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[5] J. Landeira-Fernández,et al. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. , 2007, Journal of ethnopharmacology.
[6] Dinara Jaqueline Moura,et al. Antioxidant properties of beta-carboline alkaloids are related to their antimutagenic and antigenotoxic activities. , 2007, Mutagenesis.
[7] R. Damoiseaux,et al. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. , 2007, Cell metabolism.
[8] E. Castrén,et al. Role of neurotrophic factors in depression. , 2007, Current opinion in pharmacology.
[9] Paul J Carlson,et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.
[10] D. Farzin,et al. Antidepressant-like effect of harmane and other β-carbolines in the mouse forced swim test , 2006, European Neuropsychopharmacology.
[11] R. Mcarthur,et al. Animal models of depression in drug discovery: A historical perspective , 2006, Pharmacology Biochemistry and Behavior.
[12] R. Duman,et al. A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.
[13] B. Frey,et al. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. , 2006, Life sciences.
[14] Teruo Hayashi,et al. Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release* , 2006, Journal of Biological Chemistry.
[15] M. O'Neill,et al. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment , 2004, Neuroscience.
[16] M. Barrot,et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. B. Üstün,et al. Global burden of depressive disorders in the year 2000 , 2004, British Journal of Psychiatry.
[18] Jian Wang,et al. Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine. , 2004, Biochemical and biophysical research communications.
[19] L. Stinus,et al. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs , 2002, Behavioural Brain Research.
[20] A. Rush,et al. The impact of treatment-resistant depression on health care utilization and costs. , 2002, The Journal of clinical psychiatry.
[21] E. Jutkiewicz,et al. Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats , 2002, Neuropsychopharmacology.
[22] R. Duman,et al. Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.
[23] J. Aubry,et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients , 2002, Psychiatry Research.
[24] P. Skolnick. Beyond monoamine-based therapies: clues to new approaches. , 2002, The Journal of clinical psychiatry.
[25] E. Louis,et al. TOXICOKINETICS OF TREMOROGENIC NATURAL PRODUCTS, HARMANE AND HARMINE, IN MALE SPRAGUE-DAWLEY RATS , 2001, Journal of toxicology and environmental health. Part A.
[26] D. Nutt,et al. β-carboline binding to imidazoline receptors , 2001 .
[27] Chung-Soo Lee,et al. Protective effect of harmaline and harmalol against dopamine‐ and 6‐hydroxydopamine‐induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells , 2001, The European journal of neuroscience.
[28] P Pacher,et al. Current trends in the development of new antidepressants. , 2001, Current medicinal chemistry.
[29] R. Glennon,et al. Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors , 2000 .
[30] T. Sourkes,et al. "Rational hope" in the early treatment of Parkinson's disease. , 1999, Canadian journal of physiology and pharmacology.
[31] M. Ferigolo,et al. Ethopharmacology of imipramine in the forced-swimming test: gender differences , 1998, Neuroscience & Biobehavioral Reviews.
[32] D. Charney. Monoamine dysfunction and the pathophysiology and treatment of depression. , 1998, The Journal of clinical psychiatry.
[33] J. Siuciak,et al. Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF) , 1997, Pharmacology Biochemistry and Behavior.
[34] R. Duman,et al. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[35] J. Siuciak,et al. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration , 1996, Brain Research.
[36] Michael Rickels,et al. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants , 1995, Psychopharmacology.
[37] Z. Górka,et al. Effects of neuroleptics displaying antidepressant activity on behavior of rats in the forced swimming test , 1985, Pharmacology Biochemistry and Behavior.
[38] Porsolt Rd. Animal model of depression. , 1979 .
[39] R. Kociba,et al. Induction of pulmonary carcinoma in rats by chronic inhalation of dust from pulverized asbestos pipe covering. , 1978, Journal of toxicology and environmental health.
[40] R. Porsolt,et al. Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.
[41] R. Takahashi,et al. An animal model of depression. , 1974, Biological psychiatry.
[42] D. Bylund,et al. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. , 2008, Pharmacology & therapeutics.
[43] E. Jutkiewicz,et al. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. , 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[44] R. Glennon,et al. Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors. , 2000, Drug and alcohol dependence.
[45] R. Ramsay,et al. Inhibition of monoamine oxidase A by beta-carboline derivatives. , 1997, Archives of biochemistry and biophysics.
[46] R. Ramsay,et al. Inhibition of Monoamine Oxidase A by β-Carboline Derivatives , 1997 .
[47] Y. Barde,et al. Physiology of the neurotrophins. , 1996, Annual review of neuroscience.
[48] H. Aihara,et al. Effect of chronic administration of antidepressants on duration of immobility in rats forced to swim. , 1986, Japanese journal of pharmacology.
[49] Global burden of depressive disorders in the year Global burden of depressive disorders in the year , 2022 .